Avril Avril

Avril Avril has extensive experience in the pharmaceutical industry, currently serving as the Vice President and Head of US Business Development at Shanghai Medicilon Inc. since 2012. Avril's primary focus encompasses business development and project management for integrated drug discovery services, including chemistry, structural biology, and preclinical studies, guiding projects from initial hits to lead compounds and preparing IND-filing package studies. Prior roles include Director at Shanghai Medicilon Inc., Scientist II at Neurocrine Biosciences specializing in medicinal chemistry, Staff Scientist at DuPont Pharmaceuticals, and Postdoctoral Fellow at Scripps Research.